More on IN
Data
Financials
News
Click line-items for a historical chart and %
| Cash and cash equivalents at beginning of the period | 85.17M |
| Net loss | -23.1M |
| Depreciation and amortization | 15.74M |
| Impairment of facility | |
| Deferred taxes | |
| Stock-based compensation | 3.54M |
| Accounts receivable | 8.63M |
| Inventories | 11.68M |
| Accounts payable | -11.63M |
| Payroll and related expenses | -773K |
| Accrued expenses | -201K |
| Deferred revenue | 12.55M |
| Other operating activities | -484K |
| Net cash used in operating activities | 19.01M |
| Acquisitions, net of cash acquired | |
| Additions to property, plant and equipment | -5.21M |
| Other investing activities | -682K |
| Net cash used in investing activities | -5.9M |
| Proceeds from issuance of debt | |
| Repayment of debt | |
| Stock repurchase | |
| Stock options exercised and other | |
| Net cash provided by financing activities | -1.77M |
| Effect of exchange rate changes on cash and cash equivalents | -1.79M |
| Resulting decrease in cash and cash equivalents | 9.54M |
| Cash and cash equivalents at end of the period | 94.71M |
